Search Results - "International journal of cancer"

Cancer statistics for the year 2020: An overview by Ferlay, Jacques, Colombet, Murielle, Soerjomataram, Isabelle, Parkin, Donald M., Piñeros, Marion, Znaor, Ariana, Bray, Freddie

“…Our study briefly reviews the data sources and methods used in compiling the International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics for…”
Get full text

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods by Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D.M., Piñeros, M., Znaor, A., Bray, F.

“…Estimates of the worldwide incidence and mortality from 36 cancers and for all cancers combined for the year 2018 are now available in the GLOBOCAN 2018…”
Get full text

In search of definitions: Cancer‐associated fibroblasts and their markers by Nurmik, Martin, Ullmann, Pit, Rodriguez, Fabien, Haan, Serge, Letellier, Elisabeth

“…The tumor microenvironment has been identified as one of the driving factors of tumor progression and invasion. Inside this microenvironment, cancer‐associated…”
Get full text

Worldwide burden of cancer attributable to HPV by site, country and HPV type by de Martel, Catherine, Plummer, Martyn, Vignat, Jerome, Franceschi, Silvia

“…HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of other anogenital cancers and oropharyngeal cancers…”
Get full text

International trends in hepatocellular carcinoma incidence, 1978–2012 by Petrick, Jessica L., Florio, Andrea A., Znaor, Ariana, Ruggieri, David, Laversanne, Mathieu, Alvarez, Christian S., Ferlay, Jacques, Valery, Patricia C., Bray, Freddie, McGlynn, Katherine A.

“…Primary liver cancer, the major histology of which is hepatocellular carcinoma (HCC), is the second leading cause of cancer death worldwide. We comprehensively…”
Get full text

Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies by Piha‐Paul, Sarina A., Oh, Do‐Youn, Ueno, Makoto, Malka, David, Chung, Hyun Cheol, Nagrial, Adnan, Kelley, Robin K., Ros, Willeke, Italiano, Antoine, Nakagawa, Kazuhiko, Rugo, Hope S., Braud, Filippo, Varga, Andrea Iolanda, Hansen, Aaron, Wang, Hui, Krishnan, Suba, Norwood, Kevin G., Doi, Toshihiko

“…We present data from patients with advanced biliary tract cancer (BTC) receiving pembrolizumab in the KEYNOTE‐158 (NCT02628067; phase 2) and KEYNOTE‐028…”
Get full text

Global trends in colorectal cancer mortality: projections to the year 2035 by Araghi, Marzieh, Soerjomataram, Isabelle, Jenkins, Mark, Brierley, James, Morris, Eva, Bray, Freddie, Arnold, Melina

“…Colorectal cancer (CRC) is the third most common cancer worldwide and the fourth most common cause of cancer death. Predictions of the future burden of the…”
Get full text

Risk factors for endometrial cancer: An umbrella review of the literature by Raglan, Olivia, Kalliala, Ilkka, Markozannes, Georgios, Cividini, Sofia, Gunter, Marc J., Nautiyal, Jaya, Gabra, Hani, Paraskevaidis, Evangelos, Martin‐Hirsch, Pierre, Tsilidis, Kostas K., Kyrgiou, Maria

“…Although many risk factors could have causal association with endometrial cancer, they are also prone to residual confounding or other biases which could lead…”
Get full text

Global cancer incidence in older adults, 2012 and 2035: A population‐based study by Pilleron, Sophie, Sarfati, Diana, Janssen‐Heijnen, Maryska, Vignat, Jérôme, Ferlay, Jacques, Bray, Freddie, Soerjomataram, Isabelle

“…Population ageing has substantially contributed to the rising number of new cancer cases worldwide. We document cancer incidence patterns in 2012 among older…”
Get full text

A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale by Clifford, Gary M., Georges, Damien, Shiels, Meredith S., Engels, Eric A., Albuquerque, Andreia, Poynten, Isobel Mary, Pokomandy, Alexandra, Easson, Alexandra M., Stier, Elizabeth A.

“…Certain population groups are known to have higher than average anal cancer risk, namely persons living with HIV (PLHIV), men who have sex with men (MSM),…”
Get full text

Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trial by Becker, Nikolaus, Motsch, Erna, Trotter, Anke, Heussel, Claus P., Dienemann, Hendrik, Schnabel, Philipp A., Kauczor, Hans‐Ulrich, Maldonado, Sandra González, Miller, Anthony B., Kaaks, Rudolf, Delorme, Stefan

“…In 2011, the U.S. National Lung Cancer Screening Trial (NLST) reported a 20% reduction of lung cancer mortality after regular screening by low‐dose computed…”
Get full text

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 by Ferlay, Jacques, Soerjomataram, Isabelle, Dikshit, Rajesh, Eser, Sultan, Mathers, Colin, Rebelo, Marise, Parkin, Donald Maxwell, Forman, David, Bray, Freddie

“…Estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012 are now available in the GLOBOCAN series of the…”
Get full text

Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050 by Pilleron, Sophie, Soto‐Perez‐de‐Celis, Enrique, Vignat, Jerome, Ferlay, Jacques, Soerjomataram, Isabelle, Bray, Freddie, Sarfati, Diana

“…Using GLOBOCAN estimates, we describe the estimated cancer incidence among adults aged 80 years or older at the regional and global level in 2018, reporting…”
Get full text

Potential of long non‐coding RNAs in cancer patients: From biomarkers to therapeutic targets by Chandra Gupta, Subash, Nandan Tripathi, Yashoda

“…Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non‐coding RNAs…”
Get full text

ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients by Fekete, János T., Győrffy, Balázs

“…Systemic therapy of breast cancer can include chemotherapy, hormonal therapy and targeted therapy. Prognostic biomarkers are able to predict survival and…”
Get full text

Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020 by Cabasag, Citadel J, Fagan, Paula J, Ferlay, Jacques, Vignat, Jerome, Laversanne, Mathieu, Liu, Lihua, van der Aa, Maaike A, Bray, Freddie, Soerjomataram, Isabelle

“…Ovarian cancer remains to have relatively poor prognosis particularly in low-resourced settings. It is therefore important to continually examine the burden of…”
Get full text

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review by Pandey, Kamal, An, Hee‐Jung, Kim, Seung Ki, Lee, Seung Ah, Kim, Sewha, Lim, Sun Min, Kim, Gun Min, Sohn, Joohyuk, Moon, Yong Wha

“…Deregulation of the cyclin D‐CDK4/6‐INK4‐RB pathway leading to uncontrolled cell proliferation, is frequently observed in breast cancer. Currently, three…”
Get full text

Liquid biopsies: Potential and challenges by Heidrich, Isabel, Ačkar, Lucija, Mossahebi Mohammadi, Parinaz, Pantel, Klaus

“…The analysis of tumor cells or tumor cell products obtained from blood or other body fluids (“liquid biopsy” [LB]) provides a broad range of opportunities in…”
Get full text

Fecal microbiota transplantation in cancer management: Current status and perspectives by Chen, Danfeng, Wu, Jingyi, Jin, Duochen, Wang, Bangmao, Cao, Hailong

“…The human gut is home to a large and diverse microbial community, comprising about 1,000 bacterial species. The gut microbiota exists in a symbiotic…”
Get full text

Thyroid cancer mortality and incidence: A global overview by Vecchia, Carlo, Malvezzi, Matteo, Bosetti, Cristina, Garavello, Werner, Bertuccio, Paola, Levi, Fabio, Negri, Eva

“…In most areas of the world, thyroid cancer incidence has been appreciably increasing over the last few decades, whereas mortality has steadily declined. We…”
Get full text